Select an option below to continue reading this premium story.
Already a Honolulu Star-Advertiser subscriber? Log in now to continue reading.
Legal battles take what seems like an eternity, and Tuesday’s announcement about a $916 million litigation award from makers of the anticoagulant drug Plavix is not the last word. Bristol-Meyers Squibb and Sanofi intend to appeal the award made by the state Circuit Court.
But it’s already a win if the state does benefit substantially because the limited effectiveness for those of Asian and Pacific ancestry wasn’t first presented to patients. It’s good to see this population, underrepresented in research, acknowledged, and good that the state is continuing this important fight.
Correction: A Hawaii judge awarded $916 million to the state in a lawsuit against Bristol-Meyers Squibb and Sanofi related to the drug Plavix. The companies intend to appeal the award. An earlier version of this Off the News item and its headline said the companies had agreed to a “settlement.”